Skip to main content
An official website of the United States government

Cancer Research Legislation

This page provides summaries of legislation proposed in the 118th Congress affecting cancer research policy. This page will be updated as relevant legislation is introduced.

Comprehensive Cancer Survivorship Act (H.R. 4363 & S. 2213)

  • The bill would aim to address the health of cancer survivors and unmet needs that survivors face through the entire continuum of care from diagnosis through active treatment and post-treatment, including by developing a minimum standard of care for cancer survivorship. Among other provisions, the legislation would require HHS to conduct a landscape analysis for an Adult Cancer Survivorship Study modeled after NCI’s Childhood Cancer Survivor Study (CCSS) and submit a report on the results to Congress.

Fairness to Kids with Cancer Act of 2023 (H.R. 5405)

  • The bill would require a certain percentage of federal cancer research funds be used for pediatric cancer research. 

Give Kids a Chance Act (S. 2897 & H.R. 3433)

  • The legislation would authorize the FDA to direct drug companies to develop pediatric study plans for combinations of targeted therapies when relevant for childhood cancers.

Triple-Negative Breast Cancer Research and Education Act of 2023 (H.R. 235)

  • This legislation would provide for research and education with respect to triple-negative breast cancer.

Women and Lung Cancer Research and Preventative Services Act of 2023 (H.R. 4534)

  • This legislation would require the HHS Secretary, in consultation with the Secretary of the Department of Defense (DOD) and Secretary of the Department of Veterans Affairs (VA), to conduct an interagency review to identify opportunities related to research on women and lung cancer, women’s access to lung cancer preventive services, and public awareness campaigns on lung cancer.
  • Updated: